THC, US88033G4073

Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised

Published on 11/03/2026 at 02:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Tenet Healthcare raised its 2026 adjusted EBITDA outlook after strong third-quarter results. Revenue and adjusted earnings also advanced year over year.

Tenet strengthens its 2026 outlook

  • Third-quarter adjusted diluted earnings per share rose 79.5 percent year over year.
  • Adjusted EBITDA increased 23.3 percent, helped by hospital operations and ambulatory care.
  • Tenet raised its full-year adjusted EBITDA and adjusted free cash flow outlook.
THC, US88033G4073, Illustration mit AI erstellt.

Tenet Healthcare reported stronger third-quarter results on October 29, 2026, and raised its full-year adjusted EBITDA outlook. The Dallas-based healthcare services company said adjusted diluted earnings per share increased 79.5 percent year over year to 6.64 US dollars, while adjusted EBITDA rose 23.3 percent to 1.355 billion US dollars.

Tenet Healthcare's investor release said third-quarter net operating revenue increased 6.5 percent to 5.631 billion US dollars. Net income available to common shareholders reached 1.000 billion US dollars, compared with 342 million US dollars in the prior-year quarter.

Higher outlook includes special effects

Tenet now expects full-year adjusted EBITDA of 5.050 billion to 5.200 billion US dollars, with the midpoint 195 million US dollars above its previous outlook. Adjusted free cash flow is expected in a range of 2.825 billion to 3.125 billion US dollars.

The quarter included a favorable net adjusted EBITDA impact of 147 million US dollars from the transition of revenue-cycle management services under agreements with CommonSpirit Health. Tenet said the amount included a 97 million US dollar timing-related revenue adjustment and an approximately 50 million US dollar benefit from transition activities. The company also noted that lower exchange admissions weighed on payer mix.

Stock quote and investor context

Tenet Healthcare stock traded at 239.00 euros on Lang & Schwarz at 11:00 p.m. CET on Monday, November 2, 2026. Investors may follow the real-time quote of Tenet Healthcare stock.

Tenet's ambulatory segment generated 1.371 billion US dollars in third-quarter revenue and adjusted EBITDA of 537 million US dollars. Same-facility surgical cases fell 1.5 percent, while revenue per case increased 6.1 percent.

Tenet's healthcare platform and peers

Tenet Healthcare is a diversified healthcare services company headquartered in the United States. Its operations include acute-care and specialty hospitals, outpatient facilities, physician practices, revenue-cycle management and United Surgical Partners International's ambulatory surgery centers and surgical hospitals. The company competes with hospital operators such as HCA Healthcare and Universal Health Services, while Surgery Partners has a more focused ambulatory-care profile. Tenet's combination of hospital and ambulatory operations gives it a broader platform than a specialist outpatient operator.

Tenet Healthcare at a glance

  • Company: Tenet Healthcare Corporation
  • ISIN: US88033G4073
  • Ticker: THC
  • Home exchange: NYSE
  • Lang & Schwarz quote: 239.00 euros on November 2, 2026 at 11:00 p.m. CET
  • Change: -4.00 euros, or -1.65 percent, against the previous Lang & Schwarz close of 243.00 euros
  • Third-quarter adjusted EBITDA: 1.355 billion US dollars
  • 2026 adjusted EBITDA outlook: 5.050 billion to 5.200 billion US dollars

US healthcare stocks remain sensitive to reimbursement trends, hospital utilization and payer mix; investors can review the latest S&P 500 market reports.

More news and analyses on Tenet Healthcare stock

Disclaimer...
en | US88033G4073 | THC | boerse | 70448246 |